Serum uric acid - Phosphate ratio as a differential diagnostic marker of prostate disorders

K. Sudha, K. Reshma, L. N. Akshatha

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

Prostate cancer (PC), benign prostatic hyperplasia (BPH) and prostatitis are the most common disorders of the prostate gland. Prostate specific antigen (PSA), the marker of prostate cancer has shown reasonable sensitivity but has limited specificity for distinguishing PC from BPH.This study attempts to evaluate the use of uric acid phosphate ratio as a tool in differential diagnosis of prostate disorders. PSA, uric acid and phosphate were estimated in serum of 75 patients with prostate disorders .PSA levels were significantly high in PC compared to other disorders. Phosphate levels were significantly lower in prostatitis patients, and an apparent increase in uric acid levels in BPH patients. Serum uric acid phosphate ratio was markedly high in prostatitis followed by BPH patients and least in PC establishing the role of the ratio in the differential diagnosis of prostate disorders.

Original languageEnglish
Pages (from-to)B196-B200
JournalInternational Journal of Pharma and Bio Sciences
Volume5
Issue number4
Publication statusPublished - 01-01-2014

Fingerprint

Uric Acid
Prostatic Hyperplasia
Prostate
Prostatic Neoplasms
Prostate-Specific Antigen
Prostatitis
Phosphates
Serum
Differential Diagnosis

All Science Journal Classification (ASJC) codes

  • Biotechnology
  • Biochemistry
  • Molecular Biology
  • Cell Biology

Cite this

@article{0c26b28c43ab411caa4ff2bd49d43c80,
title = "Serum uric acid - Phosphate ratio as a differential diagnostic marker of prostate disorders",
abstract = "Prostate cancer (PC), benign prostatic hyperplasia (BPH) and prostatitis are the most common disorders of the prostate gland. Prostate specific antigen (PSA), the marker of prostate cancer has shown reasonable sensitivity but has limited specificity for distinguishing PC from BPH.This study attempts to evaluate the use of uric acid phosphate ratio as a tool in differential diagnosis of prostate disorders. PSA, uric acid and phosphate were estimated in serum of 75 patients with prostate disorders .PSA levels were significantly high in PC compared to other disorders. Phosphate levels were significantly lower in prostatitis patients, and an apparent increase in uric acid levels in BPH patients. Serum uric acid phosphate ratio was markedly high in prostatitis followed by BPH patients and least in PC establishing the role of the ratio in the differential diagnosis of prostate disorders.",
author = "K. Sudha and K. Reshma and Akshatha, {L. N.}",
year = "2014",
month = "1",
day = "1",
language = "English",
volume = "5",
pages = "B196--B200",
journal = "International Journal of Pharma and Bio Sciences",
issn = "0975-6299",
publisher = "International Journal of Pharma and Bio Sciences",
number = "4",

}

Serum uric acid - Phosphate ratio as a differential diagnostic marker of prostate disorders. / Sudha, K.; Reshma, K.; Akshatha, L. N.

In: International Journal of Pharma and Bio Sciences, Vol. 5, No. 4, 01.01.2014, p. B196-B200.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Serum uric acid - Phosphate ratio as a differential diagnostic marker of prostate disorders

AU - Sudha, K.

AU - Reshma, K.

AU - Akshatha, L. N.

PY - 2014/1/1

Y1 - 2014/1/1

N2 - Prostate cancer (PC), benign prostatic hyperplasia (BPH) and prostatitis are the most common disorders of the prostate gland. Prostate specific antigen (PSA), the marker of prostate cancer has shown reasonable sensitivity but has limited specificity for distinguishing PC from BPH.This study attempts to evaluate the use of uric acid phosphate ratio as a tool in differential diagnosis of prostate disorders. PSA, uric acid and phosphate were estimated in serum of 75 patients with prostate disorders .PSA levels were significantly high in PC compared to other disorders. Phosphate levels were significantly lower in prostatitis patients, and an apparent increase in uric acid levels in BPH patients. Serum uric acid phosphate ratio was markedly high in prostatitis followed by BPH patients and least in PC establishing the role of the ratio in the differential diagnosis of prostate disorders.

AB - Prostate cancer (PC), benign prostatic hyperplasia (BPH) and prostatitis are the most common disorders of the prostate gland. Prostate specific antigen (PSA), the marker of prostate cancer has shown reasonable sensitivity but has limited specificity for distinguishing PC from BPH.This study attempts to evaluate the use of uric acid phosphate ratio as a tool in differential diagnosis of prostate disorders. PSA, uric acid and phosphate were estimated in serum of 75 patients with prostate disorders .PSA levels were significantly high in PC compared to other disorders. Phosphate levels were significantly lower in prostatitis patients, and an apparent increase in uric acid levels in BPH patients. Serum uric acid phosphate ratio was markedly high in prostatitis followed by BPH patients and least in PC establishing the role of the ratio in the differential diagnosis of prostate disorders.

UR - http://www.scopus.com/inward/record.url?scp=84907999394&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84907999394&partnerID=8YFLogxK

M3 - Article

VL - 5

SP - B196-B200

JO - International Journal of Pharma and Bio Sciences

JF - International Journal of Pharma and Bio Sciences

SN - 0975-6299

IS - 4

ER -